The prospects of achieving regeneration in the central nervous system (CNS) have changed, as most recent findings indicate that several species, including humans, can produce neurons in adulthood. Studies targeting this property may be considered as potential therapeutic strategies to respond to injury or the effects of demyelinating diseases in the CNS. While CNS trauma may interrupt the axonal tracts that connect neurons with their targets, some neurons remain alive, as seen in optic nerve and spinal cord (SC) injuries (SCIs). The devastating consequences of SCIs are due to the immediate and significant disruption of the ascending and descending spinal pathways, which result in varying degrees of motor and sensory impairment. Recent therapeutic studies for SCI have focused on cell transplantation in animal models, using cells capable of inducing axon regeneration like Schwann cells (SchCs), astrocytes, genetically modified fibroblasts and olfactory ensheathing glia cells (OECs). Nevertheless, and despite the improvements in such cell-based therapeutic strategies, there is still little information regarding the mechanisms underlying the success of transplantation and regarding any secondary effects. Therefore, further studies are needed to
clarify these issues. In this review, we highlight the properties of OECs that make them suitable to achieve neuroplasticity/neuroregeneration in SCI. OECs can interact with the glial scar, stimulate angiogenesis, axon outgrowth and remyelination, improving functional outcomes following lesion.
Furthermore, we present evidence of the utility of cell therapy with OECs to treat SCI, both from animal models and clinical studies performed on SCI patients, providing promising results for future treatments.
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| I N TR ODU C TI ON
Spinal cord injury (SCI) is a secondary outcome of a compression injury, bleeding and/or ischemia, which compromises the bone component of the spine, the spinal cord (SC) and its coverings. Several mechanisms can cause this type of damage, the most common bone injury being bone disruption produced by flexo-extension injuries associated with fracture (Ahuja, Martin, & Fehlings, 2016; McDonald & Sadowsky, 2002; Rogers & Todd, 2016) . The pathological features of traumatic SCI include axon demyelination, which is in part due to the loss of the glial substrate at the site of injury as a combined result of necrosis, apoptosis and autophagy (McDonald & Sadowsky, 2002; Plemel et al., 2014) . In the days and weeks following SCI there is extensive oligodendrocyte loss and widespread demyelination, which can already be detected at 7 days post injury (DPI; Plemel et al., 2014) .
SCI generates a series of temporary anatomical and pathological changes. After the first pathological events associated with injury (see below), a secondary phase begins from 1 to 3 DPI, and a loss of blood vessels, neurons, glial cells and axonal tracts occurs in this phase. These events are responsible for the loss of function in most nervous system injuries (Botero, Gomez, & Chaparro, 2013; McDonald & Sadowsky, 2002) . As such, SCI can generally be divided into different clinical phases:
1. Acute SCI-with destruction of the blood-brain barrier, alterations to the microvasculature of the grey matter and induction of petechial haemorrhages, which has also been linked with the formation of oedema, thrombin production and erythrocyte lysis. Vascular changes and haemorrhages fulfil a crucial role in the initial pathological events leading to neuronal cell death and axonal damage (Gerzanich et al., 2009; Griffiths, Burns, & Crawford, 1978; Losey, Young, Krimholtz, Bordet, & Anthony, 2014; Yu & Fehlings, 2011) . The presence of inflammatory cells can also be observed, especially that of neutrophils, which have been detected as soon as 3 min after a contusion injury and that are related to the extent of injury (Griffiths et al., 1978; Taoka et al., 1997; Yu & Fehlings, 2011) . In addition to the vascular changes, several pathophysiological events take place after SCI.
There is a loss of ionic regulation that leads to a loss of nerve impulses and oedema formation. An increase of free intracellular calcium also occurs, which activates the proteases and phospholipases that are involved in the destruction of myelin (Balentine, 1988) . Glutamate and aspartate release also produces the excessive excitation of viable neurons and there is a disruption of redox homeostasis, with the consequent generation of free radicals (e.g., superoxide anions, hydrogen peroxide, hydroxyl anions, and so on (Tator & Fehlings, 1991) .
2. Subacute SCI-in which glial cell activation occurs as a result of necrosis, haemorrhage and local ischemia, and in which neuronal and oligodendroglial apoptosis takes place (Spitzbarth et al., 2011; Tator & Koyanagi, 1997; Yu & Fehlings, 2011) .
3. Chronic SCI-in which the degenerative process continues and extends beyond the primary lesion (Gomez, 2009; McDonald & Sadowsky, 2002; Tator & Koyanagi, 1997) .
Glial and neuronal degeneration, and demyelination is evident in each of these phases, with morphological and structural abnormalities in both the grey and white matter associated with complete SCI (Botero, 2015; McDonald & Sadowsky, 2002) .
After SCI, severe functional deficits generally appear as a result of the disconnection in the spinal tract, a condition that persists due to the poor capacity for spontaneous axonal regeneration of the neurons implicated. This is due to several problems: (i) intrinsic neuronal deficits in the expression of genes implicated in axon regrowth/regeneration (Bomze, Bulsara, Iskandar, Caroni, & Skene, 2001; Hannila & Filbin, 2008) ; (ii) the presence of inhibitory factors in the glial scar that develops after trauma (Cregg et al., 2014; Silver & Miller, 2004; Yiu & He, 2006) ; and (iii) a lack of trophic factors for neuroprotection and regeneration (Jones, Oudega, Bunge, & Tuszynski, 2001; Sharma, 2007) .
Functional recovery from the SCI depends on its pathophysiology (Tator, 1998) and different therapeutic strategies have been considered to achieve this, both individually and in combination. These strategies include approaches that involve the provision of neurotrophic factors, overcoming glial scar inhibitory factors and cell transplantation (Assinck, Duncan, Hilton, Plemel, & Tetzlaff, 2017; Bunge, 2008; Jones et al., 2001; Moreno-Flores and Avila, 2010) . Glial cell transplantation aims to provide neuroprotection and/or promote the plasticity/myelination of spared fibres, and/or to foster axon regeneration. Stem cell transplantation aims to provide new glial cells for myelination or neuroprotection, or new neurons to replace the lost ones and/or to provide synaptic relays (Erceg et al., 2010; Lu et al., 2012; Moreno-Flores & Avila, 2010; Moreno-Manzano et al., 2009; Okano, 2002; Zurita & Vaquero, 2006; Zurita et al., 2008) . In animal SCI models of diverse severity, promising results have been obtained by transplanting different cell types, such as:
Schwann cells (SchCs) or peripheral nerve grafts (Cheng, Cao, & Olson, 1996; Kanno, Pearse, Ozawa, Itoi, & Bunge, 2015) .
Olfactory ensheathing glia cells (OECs: Li, Field, & Raisman, 1997; Lopez-Vales, Fores, Verdu, & Navarro, 2006; Lu, Feron, Ho, MackaySim, & Waite, 2001; Ramon-Cueto & Nieto-Sampedro, 1994;  Ramon-Cueto, Plant, Avila, & Bunge, 1998; Ramon-Cueto, Cordero, Santos-Benito, & Avila, 2000) .
Genetically modified OECs .
Olfactory mucosa (OM) grafts (Iwatsuki et al., 2008) .
Different types of stem cells (Assinck et al., 2017; Deshpande et al., 2006; Erceg et al., 2010; Lu et al., 2012; Okano, 2002) , including ependymal stem cells (Moreno-Manzano et al., 2009) , bone marrow mesenchymal stem cells (Laroni, Novi, Kerlero de Rosbo, & Uccelli, 2013; Novikova, Brohlin, Kingham, Novikov, & Wiberg, 2011; Urdzikova et al., 2006; Zurita & Vaquero, 2006; Zurita et al., 2008) and mesenchymal stem cells (MSCs) from the human mucosa lamina propria (OM-MSCs: (Lindsay, Riddell, & Barnett, 2010; .
Fibroblasts and genetically modified fibroblasts (GMFs: Franzen, Martin, Daloze, Moonen, & Schoenen, 1999; Grill, Murai, Blesch, Gage, & Tuszynski, 1997; Tuszynski, Murai, Blesch, Grill, & Miller, 1997) .
This review focuses on OECs due to their inherent ability to support the continuous renewal of olfactory neurons in the olfactory system, and their ability to stimulate axon repair/plasticity/sparing and functional recovery in the central nervous system (CNS; Franssen, de Bree, & Verhaagen, 2007; Moreno-Flores, DiazNido, Wandosell, & Avila, 2002; Ramon-Cueto & Valverde, 1995) .
| ON TOG EN Y OF OL F AC TORY E N SHE A THI N G G LI A CE L LS (OE CS)
OECs are a type of macroglia located in the OM lamina propria (LP) of the peripheral nervous system (PNS) and in the CNS, in the external layer of the olfactory bulb (OB), the olfactory nerve layer (ONL). These cells are organized along the pathway from the OM to the OB and they are derived from the embryonic ectoderm in the olfactory placodes at the lateral-face of the embryo's head. It is from this region that the migratory mass that gives rise to the olfactory nerve originates.
Finally, the cells and bundles of axons of this mass reach the prospective OB in the telencephalic vesicle, which originates from the mantle of the forebrain (Chuah & Au, 1991; Doucette, 1990; Doucette, 1993; Miller, Treloar, & Greer, 2010; Ramon-Cueto & Valverde, 1995; Valverde, Santacana, & Heredia, 1992) .
Recent studies established a dual source of OECs, implicating the neural crest in their origin together with the ectodermal placodes (Katoh et al., 2011) . Indeed, more recent studies using fate-mapping techniques and genetic lineage tracing suggest that OECs are exclusively derived from the neural crest ( Figure 1 ; Barraud et al., 2010; Forni, Taylor-Burds, Melvin, Williams, & Wray, 2011) . These neural crest cells would later contribute to the ectodermal derived cranial placodes (Forni et al., 2011) and therefore, OECs share a common developmental lineage with SchCs. This modifies the previous model of OEC development and it could explain the similarities between both types of cells (Barraud et al., 2010; Forni et al., 2011) . Moreover, because stem cells from the neural crest persist in adult tissue, these cells could provide an accessible source of OECs for autologous SCI therapy (Barraud et al., 2010) .
The normal physiology of OECs in the adult is not yet well understood. In the mature olfactory neuroepithelium (Figure 2 ), sensory neurons renew with a turnover of around 28 days (Chuah & West, 2002) .
New olfactory neurons extend an apical dendrite and a basal axon, and these new axons fasciculate with other ones to grow in the right direction through the LP (connective tissue), cross the cribriform plate of the ethmoids, and finally reach the OB in the CNS to connect with their targets in the glomeruli (Chuah & West, 2002) . Two types of neural stem cells coexist in the adult olfactory epithelium, the globose basal cells (GBCs) and the horizontal basal cells (HBCs, see Figure 2 ; Carr, Farbman, Colletti, & Morgan, 1991; Frisch, 1967; Graziadei & Graziadei, 1979; Holbrook, Szumowski, & Schwob, 1995) . The former are the main source of neurons that give rise to the main cell populations of
The neural crest as a source of OECs during development. OEC-precursors originate exclusively from the neural crest. During development, these OEC-precursors migrate to the olfactory placodes (OP; green) to subsequently form part of the olfactory system. Figures were produced using Servier Medical Art G OMEZ ET AL. | 1269 the mucosa, whereas the second cell type (HBCs) are normally inactive, although they can be activated to generate new GBCs and reconstitute the population of the olfactory epithelium after extreme injury (Carter, MacDonald, & Roskams, 2004; Leung, Coulombe, & Reed, 2007) . However, the true origin of new OECs in vivo has not yet been fully clarified and thus, it is still not clear how the turnover of OECs in the adult mucosa takes place. Some in vitro studies suggest that HBCs could give rise to new OECs, perhaps through intermediate steps involving precursor cells (Carter et al., 2004) . Nevertheless this process might be very slow or rare in vivo. In this sense, it was shown that OECs do not divide or noticeably migrate within the olfactory system in response to a lesion of the OM (zinc sulphate irrigation). These studies suggest that regenerating olfactory nerve processes grow through conduits of remaining OECs, implying that these cells and their conduits persist as "pathways" for regenerating fibres (Williams, Franklin, & Barnett, 2004) .
| OL F AC TOR Y CE LL CH A RA C TER I STI CS A N D TH EI R ORI G IN S I N TH E OM OR OB
OECs are elongated in shape with a thin laminar process that wraps around the olfactory nerves in situ, while they are characterized by their flat, bipolar or multipolar morphology in culture Vincent, West, & Chuah, 2005) . OECs are present in both the peripheral olfactory nerve and in the ONL of the OB in the CNS (Vincent et al., 2005) . They express several recognized markers (Figure 3a ,b) that can be detected by immunostaining in vitro and in vivo (Alexander, Fitzgerald, & Barnett, 2002; Gomez et al., 2016; Vincent et al., 2005) . However, the expression of these proteins depends on their state of differentiation and their location in the CNS or PNS (Vincent et al., 2005) . In the adult OB in vivo (Figure 3a) , OECs express S100b, an intracellular calcium binding protein, and the intermediate filament protein GFAP (glial fibrillary acidic protein), albeit more weakly. In addition, OECs located in the outer area of the ONL of the OB weakly express the low-affinity NGF receptor, p75NTR, and the embryonic form of the neural cell adhesion molecule, E-NCAM. By contrast, in the inner area of the ONL these cells express neuropeptide Y (NPY) but not p75NTR or E-NCAM (Barnett, Hutchins, & Noble, 1993; Ubink, Halasz, Zhang, Dagerlind, & Hokfelt, 1994; Valverde et al., 1992; Vincent et al., 2005) . In the adult mouse, cells containing S100 are distributed throughout the ONL, and p75NTR also appears to be restricted to the olfactory nerve and the outer ONL. While NPY positive OEC processes are located in the inner ONL, GFAP positive processes appear to be distributed in the inner ONL, at the ONL/glomerular layer (GL) boundary and in the glomerular layer, defining loosely aggregated axon fascicles that enter the glomeruli obliquely (Au, Treloar, & Greer, 2002) .
However, a population of unidentified glial cells positive for GFAP but not S100 has also been detected .
During the in vitro characterization of the OECs obtained from cultures of the neonatal rat OB, subpopulations of cells have been FIG URE 2 A schematic representation of the adult olfactory system. The cellular composition and the diverse parts of the olfactory system are shown. GBCs are the main cells that produce neurons as they proliferate (auto-renewal) and generate new olfactory neurons, ORN. These cells extend an apical dendrite and a basal axon across the LP, to reach their targets in the olfactory glomeruli situated in the CNS. There, they establish connections with mitral and tufted cells that send information through the olfactory tract to the olfactory cortex. HBCs are usually inactive but when severe injury occurs, they can self-renew and generate most of the olfactory cells needed to restock the olfactory epithelium. HBCs may also be able to generate new OECs. Abbreviations: CNS 5 central nervous system, GBC 5 globose basal cells, HBC 5 horizontal basal cells, LP 5 lamina propria, OEC 5 olfactory ensheathing cells, ONL 5 olfactory nerve layer, ORNi 5 immature olfactory receptor neuron, ORNm 5 mature olfactory receptor neuron, PNS 5 peripheral nervous system. Figures were produced using Servier Medical Art found with morphological and proteomic features similar to those described above (Figure 3b ). These subpopulations were defined as:
(i) astrocyte-like, similar in morphology to flattened astrocytes, and characterized by the expression of E-NCAM and GFAP (fibrous appearance) and (ii) SchC-like, spindle shaped, similar in morphology to SchCs, and characterized by the expression of p75NTR, weak (diffuse) GFAP expression and a lack of E-NCAM .
Although these studies described the existence of these two populations of OECs in vitro and in vivo Pixley, 1992) , it is not possible to accurately determine if these two populations exist in the ONL of the OB, as variations in protein expression at different stages of development cannot be ruled out. In addition, the acquisition of different morphologies and markers by clonal OECs in response to the culture conditions must be considered (Alexander et al., 2002; Moreno-Flores et al., 2003a; Moreno-Flores et al., 2003b; Pixley, 1992; Vincent et al., 2005) . Furthermore, OECs are migratory cells Nocentini et al., 2012; Reginensi et al., 2015; Windus, Claxton, Allen, Key, & St John, 2007) and dynamic lamellipodal waves are crucial for cell migration (Windus et al., 2007) . Through the re-organization of the cytoskeleton, different phenotypes with flattened and spindle-shaped morphologies can be generated (the morphological characteristics of astrocytes and SchCs, respectively), producing unique OEC subpopulations that can spontaneously transform from one to the other .
Finally, other potential phenotypic OEC markers have been described, such as Calponin, an actin binding protein associated with smooth muscle contraction and smooth muscle a-actin, and a marker that can help differentiate OECs from SchCs in vitro and in vivo (Boyd et al., 2006; Jahed et al., 2007; Rizek & Kawaja, 2006) . However, conflicting results have been obtained when trying to test these markers (Ibanez, Ito, Zawadzka, Jeffery, & Franklin, 2007) , and calponin expression defined subpopulations of mucosal connective tissue cells rather than OECs in embryonic and neonatal tissue. In vitro punctate staining appears to be non-specific, seen also in astrocytes and fibroblasts FIG URE 3 OECs express different specific markers. (a) OECs have different antigenic phenotypes depending on their location in the CNS or PNS. Generally, OECs express vimentin, S100b and GFAP, although they also can express p75NTR, E-NCAM or NPY depending on the region of the CNS or PNS where they are situated. (b) In vitro, OECs can be segregated into two phenotypic subpopulations: (i) Schwann cell-like, characterized by a spindle shape and strong p75NTR expression and (ii) astrocyte-like, with a similar morphology to flattened astrocytes and strong E-NCAM expression. GFAP immunostaining in culture has been defined as fibrous for astrocyte-like OECs , yet in our experience (Moreno-Flores et al., 2003b) this staining is always diffuse in OECs, corresponding to weak GFAP expression (in western blots) relative to cultured astrocytes. Abbreviations: CNS 5 central nervous system, GFAP 5 glial fibrillary acidic protein, GL 5 glomerular layer, LP 5 lamina propria, NCAM 5 neural cell adhesion molecule, NPY 5 neuropeptide Y; OECs 5 olfactory ensheathing cells, ONL 5 olfactory nerve layer, PNS 5 peripheral nervous system. Figures were produced using Servier Medical Art G OMEZ ET AL. | 1271 (Tome, Siladzic, Santos-Silva, & Barnett, 2007) , and therefore, calponin seem not be a specific OEC marker.
A growing number of studies have been performed to obtain OECs in vitro from different sources of tissue: from the OB or OM of neonatal, early post-natal and young rodents (Au & Roskams, 2002; Au & Roskams, 2003; Barnett et al., 1993; Gomez et al., 2016; Pixley, 1992) ; from adult rodents (Jani & Raisman, 2004; Ramon-Cueto & Nieto-Sampedro, 1992) ; or from young and adult humans Garcia-Escudero et al., 2012; Jani & Raisman, 2004; Lim et al., 2010 ). It has not been possible to extract accurate generalizations from these studies due to the difficulty in comparing results from such a variety of sources, and given the different culture techniques that have been employed and the distinct antigenic features have been used to define OECs in each. Moreover, while OB and OM derived cells have been evaluated in vitro and in vivo, there is still no consensus regarding the "adequate" regenerative histological features or on the use of OECs derived from different sources. Nevertheless, the culture method (Garcia-Escudero et al., 2012) and composition of these cultures seems to be fundamental to the nature of the cells obtained (Ibrahim et al., 2014; Jani & Raisman, 2004; Mayeur et al., 2013) . It was proposed that OM and OB derived OECs both have the same potential, both reducing astrocyte reactivity and hindering the formation glial scar, as well as promoting axonal regrowth, and electrophysiological and functional recovery (Mayeur et al., 2013) . Moreover, it was concluded that the accessibility of OM-OECs gave them the best benefit/risk ratio. OM and OB OECs were also compared in a rat transplantation model of SCI and although they exhibit some distinct properties (see below "OEC transplantation in animal models of SCI"), both reduced the size of the lesion and of the cavity in the SC, and provoked differential sprouting of spinal axon tracts (Richter, Fletcher, Liu, Tetzlaff, & Roskams, 2005) . Despite the possible biological differences between these types of OECs, both have neuroregenerative properties, fostering axon outgrowth from adult CNS neurons in culture (GarciaEscudero et al., 2012) . Nevertheless, it should be noted that cultures from a dissected OM can contain a small proportion of p75NTR-positive cells, which could explain the lack of an effect of the OM cells when transplanted in a rat model of rhizotomy, as opposed to that of cells cultured from the OB. OM cells failed to produce axonal regrowth across the severed roots and functional restoration (forepaw grafting: Ibrahim et al., 2014; Li, Carlstedt, Berthold, & Raisman, 2004) . However, the results of clinical studies (Tabakow et al., 2013; Tabakow et al., 2014) should also be considered in this regard (see Section 6). In Such variety in the stem cells and OECs in the OM was also proposed following clinical studies of OM grafts transplanted into regions of SCI (Lima et al., 2006) , and the OM has recently been confirmed as a potential source of adult stem cells (Feron, Perry, Girard, & MackaySim, 2013; Girard et al., 2011; Lindsay et al., 2013; Lindsay, Johnstone, McGrath, Mallinson, & Barnett, 2016; Nivet et al., 2011; Stamegna et al., 2014; Tome, Lindsay, Riddell, & Barnett, 2009 ). In addition to OECs, human OM biopsies contain up to 5% mesenchymal-like stromal cells from the LP. Using miRNA-based fingerprinting these cells were shown to be 64% homologous to bone marrow-derived MSCs (BM-MSCs; Lindsay et al., 2016) , although they also had other specific properties. OM-MSCs differed from classical BM-MSCs through their anti-inflammatory properties, secreting less pro-inflammatory cytokines, and their stronger capacity to promote rat oligodendrocyte myelination in vitro (Lindsay et al., 2016) . These cells maintain the properties of all MSCs in general and the specific properties of OM-MSCs in particular. Therefore, they may be a good alternative for transplantation after SCI or CNS lesions (Assinck et al., 2017; Laroni et al., 2013) .
| M OLE CU L AR F EA TU R E S A ND CE LL U LA R F U NCT I ONS OF OE CS
The adult olfactory system is composed of the OM, which contains the peripheral sensory neurons whose axons form the olfactory nerve, and the OB that is part of the CNS. During the lifetime of a mammal, olfactory sensory neurons die regularly as a result of environmental exposure and they are replaced by newly differentiated neurons. These new neurons grow axons that enter the OB and establish new synapses with their targets (Costanzo, 1985; Doucette, Kiernan, & Flumerfelt, 1983; Farbman, 1994; Graziadei & Graziadei, 1979; Harding, Graziadei, Monti Graziadei, & Margolis, 1977) . This remarkable capacity of the olfactory system is due to the special properties of the glia cells on which this review focuses, OECs (Doucette, 1984; Doucette, 1990; Doucette, 1991; Raisman, 1985) . In addition, precursors in the stem niche of the olfactory system and the characteristics of OECs enable functional neural connections with targets in the CNS to be reestablished after injury (e.g., transection of the olfactory nerve: Doucette, 1984; Doucette et al., 1983; Doucette, 1995; Harding et al., 1977) .
OECs perform specific functions within the olfactory system. In the OM they provide a favorable environment for the development of sensory axons, which fasciculate to form the first cranial nerve, and that grow through these territories to enter the CNS and establish functional synapses in the OB glomeruli. OECs ensheath, accompany and guide these axons from the OM to the OB (Doucette, 1990; Doucette, 1995; Moreno-Flores et al., 2002; Ramon-Cueto & Valverde, 1995) . OECs and olfactory axons maintain communication by evoking calcium signals via glutamatergic and purinergic pathways (Rieger, Deitmer, & Lohr, 2007) , and these axons do not establish synapses until they arrive at the glomeruli in the OB. The cytoplasmic prolongations of OECs envelop these packages of axons, acting as an insulator and ensuring they avoid coming into contact with other inhibitory CNS factors that would otherwise restrict axonal growth.
The molecular mechanisms by which OECs support axonal outgrowth are yet not fully understood, although several of the molecules responsible for this capacity have been identified in recent years. OECs are known to express a number of proteins that can aid such events, including membrane bound and secreted adhesion molecules that promote axonal growth (Table 1a & Figure 4 ): L1, E-NCAM, laminin, fibronectin, type IV collagen, and amyloid precursor protein (APP; Doucette, 1996; Kafitz & Greer, 1998; MorenoFlores et al., 2003a) . These molecules can act as favorable substrates for axonal growth, and laminin in particular is a preferential substrate for in vitro neurite extension by olfactory neurons (Kafitz & Greer, 1997) .
OECs are also characterized by the secretion of diffusible factorsneurotrophins (NTs) and other trophic factors responsible for neurite extension by olfactory neurons in vitro (Kafitz & Greer, 1999) . NTs fulfil an important role in neuronal development, promoting proliferation, survival or axonal outgrowth (Huang & Reichardt, 2001; Huang & Reichardt, 2003) through their specific tyrosine kinase receptors, Trks, which in turn activate intracellular signaling through G proteins like Ras, Rap-1 and Cdc-42 (Huang & Reichardt, 2001; Huang & Reichardt, 2003) . Cultured OECs express mRNA for nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), neurturin (NTN) and neuregulins (Boruch et al., 2001; Lipson, Widenfalk, Lindqvist, Ebendal, & Olson, 2003; MorenoFlores et al., 2002; Pastrana et al., 2007; Woodhall, West, & Chuah, 2001) , as well as their receptors TrkB, TrkC, GFRa-1 and GFRa-2 (Table   1a and Figure 4 ; Lipson et al., 2003; Woodhall et al., 2001 ). In addition, the intracellular presence and the secretion of NGF, BDNF (Pastrana et al., 2007; Woodhall et al., 2001 ) and neuregulin (Boruch et al., 2001) has been confirmed by immunocytochemistry and ELISA (Table 2) .
While some contradictory results have been obtained regarding and ciliary neurotrophic factor (CNTF) mRNA expression (Boruch et al., 2001; Lipson et al., 2003) , some of these studies were carried out on a clonal OEC line. Moreover, mRNA for S100b, CNTF, BMP7/OP-1 and artemin has been detected in the ONL of the OB, as has that encoding the RET and TrkC receptors in the ONL (Lipson et al., 2003) .
Considering their patterns of expression, it seems that some of these trophic factors may exert an autocrine effect on OECs, for example, the ligand/receptor pairs NGF/p75NTR, BDNF/TrkB, GDNF/ GFRa-1 and NTN/GFRa-2. In the case of GDNF and NTN, conflicting results have been reported regarding the expression of the transducing subunit of these receptors, RET. RET mRNA was not detected in cultured OECs, suggesting that these cells lack RET and thus, as they would be unable to transduce the signals from GDNF and NTN, and that they might simply bind and present these factors to growing neurons (Woodhall et al., 2001) . However, the subunits of these receptors and RET mRNA were detected in the ONL of the OB (Lipson et al., 2003) , where OECs constitute the main type of cell. Thus, the function of GDNF and NTN in the olfactory system still remains uncertain.
Specific neuregulins, such as NRG-1 isoforms, are trophic factors for OECs, acting through ErbB receptors (Moreno-Flores et al., 2002) given that OECs express ErbB2, 3 and 4 in culture (Table 1a ; MorenoFlores et al., 2003b; Pollock, Franceschini, Graham, Marchionni, & Barnett, 1999) . Therefore, neuregulins may also exert autocrine effects on these cells. OECs also express other molecules that have neurotrophic effects, like S100b Lipson et al., 2003; Vincent et al., 2005) , and that may fulfil important functions in brain development (Barger, Wolchok, & Van Eldik, 1992; Marshak, 1990; Modi & Kanungo, 2010) . Similarly, they produce cytokines that can play a relevant role in neuroprotection and repair (Table 1a and OECs not only express factors that promote neuroregeneration but they also express some inhibitory factors (Table 1b and (Nocentini et al., 2012; Su et al., 2007; Woodhall, West, Vickers, & Chuah, 2003) , and the latter has a direct effect on the capacity of OECs to migrate on myelin or myelinderived substrates in vitro (Nocentini et al., 2012; Reginensi et al., 2015) . Significantly, this phenomenon may affect their ability to penetrate the glial scar. Several molecules have been seen to regulate OEC migration, either positively, like GDNF (Cao et al., 2006) , or negatively like Myelin, NogoA, chondroitin sulphate proteoglycans (CSPGs; Nocentini et al., 2012; Reginensi et al., 2015; Su et al., 2007) , the axonal guidance molecule Slit-2, ligand of Robo receptors Wang & Huang, 2012) , and fibulin-3 (Vukovic et al., 2009b) . Furthermore, OECs express other inhibitory molecules (Table 1b and Figure 4) like Ephrin A1 in long passaged and immortalized OECs and secreted semaphorins (e.g., Sema3A: Table 2 ), although this is required for olfactory axon guidance and patterning of the OB (Schwarting et al., 2000) . As indicated above, a low p75NTR OEC subpopulation overexpresses the EphB2 receptor (Honore et al., 2012 ) that mediates axon repulsion (Klein, 2012; Orioli & Klein, 1997) , and LPOECs express the CSPG 4, NG2 (Au & Roskams, 2003) . The inhibitory influence of NG2 on axon growth is still highly controversial because it has been associated with both inhibitory effects (Fidler et al., 1999 ;
Tan, Colletti, Rorai, Skene, & Levine, 2006; Ughrin, Chen, & Levine, 2003) and the permissiveness of NG2 expressing cells (Busch et al., 2010; Vadivelu et al., 2015; Yang et al., 2006) . At present, new exciting findings are still emerging in this field (see Nishihara et al., 2015) and it appears that the expression of NG2 by some cells it is not necessarily correlated with the inhibition of axon regeneration. In fact, the effects (2012) Fibulin-3 Vukovic et al. (2009b) of NG2 may depend on the expression of other molecules, such as MMP9 (Vadivelu et al., 2015) or MMP14 (Nishihara et al., 2015) . (injuring the sciatic nerve for example). Under these conditions, CNS axons of DRG neurons regenerate and this is accompanied by an important increase in the levels of DRG-cAMP (Bomze et al., 2001; Neumann, Bradke, Tessier-Lavigne, & Basbaum, 2002; Qiu et al., 2002) .
| OE CS I N S P I N AL COR D I NJ U R Y ( SCI ) R EP
As a result, these neurons are no longer inhibited by myelin associated glycoprotein (MAG), an effect that is PKA dependent (Qiu et al., 2002) .
Direct intraganglionic injection of cAMP analogues (di-butyryl-cAMP)
enables DRG neurons to grow on an inhibitory substrate (in culture) and to regenerate dorsal column sensory projections after lesion in vivo (Neumann et al., 2002; Qiu et al., 2002) . In an elegant study, central sensory projections of DRG neurons were shown to regenerate in transgenic mice co-expressing the growth cone proteins GAP43 and CAP23, without the induction of a conditioning lesion (Bomze et al., 2001 ). Indeed, the regeneration of central sensory projections dependent on peripheral lesion takes place in conjunction with an increase in the expression of GAP43 by DRG neurons. Moreover, this regeneration is dependent on STAT3 activation and on the presence of IL-6, although not in all cases (Cafferty et al., 2004; Hannila & Filbin, 2008; Qiu, Cafferty, McMahon, & Thompson, 2005) . Thus, GAP43 and/or CAP23, or other alternative proteins needed for axon growth (but no longer expressed in the adult CNS), may be necessary for the regenera- binding is stabilized by small proteins called link proteins (Hardingham, 1979) . HA is considered central to the structure of the CNS ECM and the PNN is known to be rich in CSPGs that inhibit neurite outgrowth (Celio, Spreafico, De Biasi, & Vitellaro-Zuccarello, 1998; Crespo, Asher, Lin, Rhodes, & Fawcett, 2007; Rhodes & Fawcett, 2004) . Thus, in normal physiological conditions in which they do not need to regrow their dendrites or axons, adult neurons are surrounded by these stable "cages". After CNS lesion, the neuron-glia architecture is completely modified, provoking molecular changes and affecting the interactions between neural cells. Some neurons die as a direct consequence of the lesion and others die later, in a secondary process driven by neurotransmitter excitotoxicity and inflammatory responses. Soon after lesion, a glial reaction occurs giving way to the formation of a "glial scar" to re-establish the CNS glial boundary (glia limitans). This glial scar contains many elements and it is the main source of molecules that inhibit axon regeneration (Bovolenta, Wandosell, & Nieto-Sampedro, 1992; Bovolenta, Wandosell, & Nieto-Sampedro, 1993a; Bovolenta, Fernaud-Espinosa, Mendez-Otero, & Nieto-Sampedro, 1997; David & Lacroix, 2003; Sandvig, Berry, Barrett, Butt, & Logan, 2004; Silver & Miller, 2004) .
Following CNS lesion, astrocytes become hypertrophic and they express molecules that strongly inhibit axonal regrowth (e.g., CSPGs;
Bovolenta et al., 1997; Carri, Perris, Johansson, & Ebendal, 1988; Davies, Goucher, Doller, & Silver, 1999; Dou & Levine, 1994; Fidler et al., 1999; McKeon, Schreiber, Rudge, & Silver, 1991; McKeon, Hoke, & Silver, 1995; Muir, Engvall, Varon, & Manthorpe, 1989; Niederost, Zimmermann, Schwab, & Bandtlow, 1999; Smith-Thomas et al., 1994) .
Several CSPGs from reactive astrocytes are upregulated after CNS injury, including aggrecan (CSPG1), versican (CSPG2), neurocan (CSPG3) and phosphacan (Asher et al., 2000; Levine, 1994; McKeon, Jurynec, & Buck, 1999; Plant, Bates, & Bunge, 2001; Yiu & He, 2006) . By eliminating CSPG glycosaminoglycan (GAG) chains, CSPG inhibitory activity is attenuated (Bovolenta et al., 1993a; Fidler et al., 1999; McKeon et al., 1995; Moon, Asher, Rhodes, & Fawcett, 2001; Zuo, Neubauer, Dyess, Ferguson, & Muir, 1998 CSPGs (Dickendesher et al., 2012; Fisher et al., 2011; Shen et al., 2009 ). Moreover, microglia cells proliferate and also become reactive (Bovolenta, Wandosell, & Nieto-Sampedro, 1993b; Fernaud-Espinosa, Nieto-Sampedro, & Bovolenta, 1993) .
The neuronal bodies that contribute to the damaged axonal tracts in the SC lie at a distance from the site of injury. Hence, these neurons may remain alive after SCI, although the spinal tracts may be interrupted and disorganized at the lesion site, and myelin would shift from its highly structured physiological state to that of a chaotic net. Several components of the myelin net are potent inhibitors for axonal growth:
Nogo A, B, and C; MAG; and oligodendrocyte myelin glycoprotein OMgp or MOG (Filbin, 2003; He & Koprivica, 2004; Moreno-Flores & Avila, 2010; Oertle & Schwab, 2003; Raisman, 2004; Yang & Strittmatter, 2007; Yiu & He, 2003) . The receptors of these molecules present in the presumptive regenerating axons also play a fundamental role in regeneration: NgR, NgR2, and NgR3 (Yiu & He, 2006) . This picture is becoming more complete as new molecules are identified as myelin receptors: the human leukocyte immunoglobulin-like receptor B2
(LILRB2, a member of the B type subfamily of LILR receptors) and its orthologue in mice, the paired immunoglobulin-like receptor B (PirB)
that is an MHC class 1 receptor (Atwal et al., 2008 and references therein). Nogo, MAG and OMgp bind to NgR and PirB (Atwal et al., 2008) , and MAG also to binds to NgR2 but not NgR3 (Lauren, Airaksinen, Saarma, & Timmusk, 2003; Lauren et al., 2007; Venkatesh et al., 2005) . NgR couples to LINGO 1 and p75NTR or TAJ/TROY, constituting the complete receptor complex (Domeniconi et al., 2002; Fournier, GrandPre, & Strittmatter, 2001; Liu, Fournier, GrandPre, & Strittmatter, 2002; Mi et al., 2004; Park et al., 2005; Shao et al., 2005; Wang, Kim, Sivasankaran, Segal, & He, 2002; Wong et al., 2002) . This receptor complex mediates the signalling of its ligands, in turn modulating the activity of the Rho GTPases and inhibiting axonal regeneration (Niederost, Oertle, Fritsche, McKinney, & Bandtlow, 2002; Kubo, Yamaguchi, Iwata, & Yamashita, 2008; Kubo & Yamashita, 2007; McKerracher & Higuchi, 2006; Mimura et al., 2006; Yamashita, Higuchi, & Tohyama, 2002; Yamashita, Tucker, & Barde, 1999 (Adelson et al., 2012) .
Additionally, some other "negative" influences on axonal growth that direct axons to their appropriate territories during development, are also disorganized in the scar, such as axon guidance ligands and receptors, impeding axonal growth through the lesion site. In the glial scar, secreted and membrane semaphorins/receptors are expressed, like sema3A and sema4D/Plexin B1, as well as Eph receptors/ligands such as EphB3/EphrinA4 (Cregg et al., 2014; Fawcett, Schwab, Montani, Brazda, & Muller, 2012; Silver & Miller, 2004) .
Finally, another important problem that leads to deficient axon regeneration is the lack of trophic support for the injured CNS neurons.
In experimental models in vivo, the neurotrophins, FGF-2 and GDNF can all promote regrowth of different axonal tracts (Bradbury et al., 1999; Eggers et al., 2008; Kwon et al., 2007; Mills, Coumans et al., 2001; Liu et al., 1999; Menei, Montero-Menei, Whittemore, Bunge, & Bunge, 1998; Ruitenberg et al., 2003; Ruitenberg et al., 2005; Runyan & Phelps, 2009; Tuszynski et al., 1998; Xu, Guenard, Kleitman, Aebischer, & Bunge, 1995; Zhang et al., 2009) , inducing functional recovery Liu et al., 1999; Ruitenberg et al., 2003) .
| OEC transplantation in animal models of SCI
Only some cell populations in the nervous system can continuously regenerate throughout adult life, such as the olfactory receptor neurons in the context of the OEC environment Schwob et al., 2017) . Since OECs usually surround these growing olfactory axons in the adult mammalian CNS, it is reasonable to hypothesize that they might facilitate CNS axon regrowth after injury (Barnett & Chang, 2004; Franssen et al., 2007; Moreno-Flores et al., 2002; Moreno-Flores & Avila, 2010; Raisman, 2001; Raisman & Li, 2007; Richter & Roskams, 2008) . In recent years, the use of OECs to treat SCI has been studied extensively, and in fact, All these properties of OECs could make removal of the glial scar unnecessary, since a positive balance of membrane and secreted stimulating factors provided by OECs would decrease the inhibitory tendency, permitting axon repair. As such, OECs should be distributed over the lesion and thus, their capacity to migrate would be fundamental.
Indeed, OEC migration has been reported in the unlesioned SC (Deng et al., 2006; Lee et al., 2004) , being extensive in the X-irradiated SC and brain (Imaizumi, Lankford, Waxman, Greer, & Kocsis, 1998; Lankford, Sasaki, Radtke, & Kocsis, 2008; Lankford, Brown, Sasaki, & Kocsis, 2014) . Although migration in SCI was initially described (Ramon-Cueto et al., 1998) , the capacity of OECs to migrate seems to be limited or inexistent in several SC lesion models depending on the approaches adopted (Andrews & Stelzner, 2007; Collazos-Castro, Muñeton-Gomez, & Nieto-Sampedro, 2005; Lee et al., 2004; Lu et al., 2006; MorenoFlores et al., 2006; Pearse et al., 2007; Ramer et al., 2004) . When OECs were transplanted in a transection context and studied by magnetic resonance imaging (MRI), these cells failed to cross the gap of the SC . However, cells transplanted at the stump migrated a short distance, half that in the normal SC. Similar limited migration has been described in another study, yet restricted to only a small number of cells , whereas even shorter migration distances
(1 mm) were reported elsewhere (Deng et al., 2006; Ramer et al., 2004; Reginensi et al., 2015; Richter et al., 2005) .
The site of transplantation also varied in these studies, with OECs transplanted at the lesion site (Collazos-Castro et al., 2005; Pearse et al., 2007; Ramer et al., 2004; Richter et al., 2005) , outside the injury Reginensi et al., 2015; Richter et al., 2005) or both at and outside the lesion site, rostrally and caudally (Andrews & Stelzner, 2007; . In a hemisection model performed contralateral, and several mm rostral to the transplantation site, significant OEC migration was reported, albeit less than in the intact SC (Deng et al., 2006) . OEC migration from sites rostral and caudal to the lesion site was also reported elsewhere, being higher for LP cells than for those from the OB (Richter et al., 2005) . In our own experience, we detected limited migration of OECs in the dorso-ventral axis after injection at several sites, into the lesion and 1 mm caudal or rostral . Limited migration was also reported in a subsequent study and the injection pressure influenced in the distribution of the cells (Andrews & Stelzner, 2007) . However, when we quantified rostral and caudal migration (1 mm) in a SCI contusion model in which cells of an OEC line were injected laterally on both sides of the lesion, migration by modified OECs secreting the Nogo receptor ectodomain was enhanced (2 mm; Reginensi et al., 2015) . Therefore, it generally seems that OECs can migrate better in an uninjured SC than in the lesioned one. OECs seem to be able to migrate to the lesion site but when injected directly into the epicentre of the lesion, they fail to migrate out and are unable to cross the gap in some contexts.
With regards the factors that aid the migration of these cells, reactive astrocytes in the glial scar attract OECs in a model of SC hemisection by secreting TNF-a (Su et al., 2009 ). Additionally, GDNF can promote OEC migration in vivo and in vitro (Cao et al., 2006) . Our previous results reinforce the idea that most of the factors inhibiting axon elongation and regrowth after lesion may also affect OEC migration (Reginensi et al., 2015) . In fact, all the molecules thought to inhibit OEC migration-NogoA, CSPGs, fibulin-3, and Slit2-are overexpressed in CNS scars after lesion (Cregg et al., 2014; He & Koprivica, 2004; Lukovic et al., 2014; Nocentini et al., 2012; Reginensi et al., 2015; Vukovic et al., 2009a) .
In summary, multiple factors seem to be fundamental in choosing where to transplant cells. The role of OECs/glial scar interactions or the idea of bridging the gap are not negligible. For example, the cells in a transection model are probably not going to be able to cross the gap if this is not filled or bridged in some way. The best way to carry out transplantation is probably to use several injection/transplantation sites, in particular the epicentre of the lesion in conjunction with other additional points. We will address these issues further in Section 6.
| Axon repair and functional recovery
In animal models of SCI (Table 3) It is clearly fundamental to achieve functional recuperation in transplanted animals to consider OEC transplants an effective therapeutic strategy to treat SCI. One of the first studies using OECs transplants in SCI (complete transection) assessed a long survival time and after 7 months, the transplanted rats had regained the ability to use their hind limbs for scaling and they recovered a reflex to skin In subacute (7 days) SCI Survival: 1-6 weeks after.
Tracing: choleragenoid B subunit-conjugated horseradish peroxidase (CTB-HRP) injected at
L3. Examination of marked
Corticospinal somatosensory evoked potential recording and analysis.
-Open field locomotion: BBB scale.
(Continues) OECs can act directly as a physical substrate for neurite/axon growth, this being more effectively promoted when the OECs are in close contact with neurons, as demonstrated in vitro Moreno-Flores et al., 2002; Moreno-Flores et al., 2003b; Sonigra, Brighton, Jacoby, Hall, & Wigley, 1999) and in vivo (Li et al., 2005) .
OECs seem to be able to extend cytoplasmic processes and generate channel-like structures across the astroglial borders of the lesion (Andrews & Stelzner, 2007) , which would be useful for the growth of regenerating axons. These channels have an outer basal lamina overlaid by fibroblasts and a bare inner surface in contact with nerve fibres, this being postulated as a determinant for their regenerative capacity formulated as the "pathway hypothesis" (Li et al., 2005) . The capacity of
OECs to penetrate and to digest the glial scar would permit them to establish bridges, generating a pro-regenerative substrate (for references see Section 5.2.1). In addition, their ability to secrete neurotrophic factors seems to be fundamental to this effect (Lipson et al., 2003; Pastrana et al., 2007; Pellitteri, Spatuzza, Russo, & Stanzani, 2007; Pellitteri, Spatuzza, Russo, Zaccheo, & Stanzani, 2009; Sasaki, Hains, Lankford, Waxman, & Kocsis, 2006) . Their secretory profile (see Section 4) might account for the capacity of OEC grafts to facilitate the regeneration of some spinal tracts but not others in the lesioned SC, depending on their trophic requirements MorenoFlores et al., 2002) . However, this profile can be altered or improved by gene transfer (Ruitenberg et al., 2005; Ruitenberg et al., 2003) . The secretion of other factors would also contribute to the neuroregenerative properties of OECs Simon et al., 2011) . Adult neurons in the CNS are normally surrounded and stabilized by the PNN, which inhibits neurite outgrowth (Celio et al., 1998; Rhodes & Fawcett, 2004) . It was previously demonstrated that MMP2 can also digest CSPGs of the PNN in vitro (Figure 4 ) and enhance axon growth . Moreover, MMP2 can digest CSPGs in the glial scar (Figure 4 ; see Section 5.2.1), and the ability to secrete MMP2 and other proteases like PAI-1 was also fundamental for the proregenerative properties of OECs Simon et al., 2011) .
Indeed, MMP2 production correlates with corticospinal tract regeneration in vivo Pastrana et al., 2006) .
Finally, the Scavenger receptor class B member 2 (SCARB2) type III glycoprotein is produced by OECs, which is key for their neurite growth ability (Roet et al., 2013; Roet & Verhaagen, 2014) . This protein is located primarily in the limiting membranes of lysosomes and endosomes. SCARB2 gene transfer can mediate regeneration of dorsal column sensory axons in the injured SC (Roet et al., 2013; Roet & Verhaagen, 2014) , and this action is probably related to lipid transfer mechanisms and the synthesis of cholesterol-containing lipoproteins. axons is important for membrane synthesis during regeneration after injury (Boyles et al., 1989; Jurevics, Bouldin, Toews, & Morell, 1998; Li, Fowler, Neil, Colton, & Vitek, 2010) . It is known that damage in the CNS leads to the synthesis of proteins involved in lipid metabolism and cholesterol, and that pharmacological or genetic interference with cholesterol reuse dampens local axonal growth (Roet & Verhaagen, 2014) .
In summary, OECs can guide and stimulate the growth of olfactory axons towards their targets, and they can provide and regulate the lipid transfer necessary for this process (Roet & Verhaagen, 2014) . As such, it can be inferred that one of the main mechanisms for OECdependent axon repair in the CNS may rely on lipid metabolism in these cells and in their ability to transfer them to the growing axons.
| Myelination
Demyelination is widespread in the sub-chronic phase of the SCI, at 7 DPI (Blight, 1985; Plemel et al., 2014) , and it might block action potentials (Blight, 1983) or render axons more susceptible to degeneration (Irvine & Blakemore, 2008; Plemel et al., 2014) . However, axonal conduction can be achieved without remyelination, even if denuded axons persist in association with demyelinating lesion (Felts, Baker, & Smith, 1997) , and deficits in electrical conduction may occur that are not due to demyelination. Significantly, such acute deficiencies were not evident contralateral to the lesion but they developed 1-2 weeks later, and they persisted in chronic states when remyelination should have taken place (Arvanian et al., 2009; Plemel et al., 2014) . There are many issues to clarify regarding the persistence of oligodendrocyte death (over weeks) and demyelination after SCI. Therefore, remyelination as an intervention strategy after SCI remains controversial, even though it is generally considered an important therapeutic target (Plemel et al., 2014) . Hence, in this section we will consider the capacity of OECs to produce myelination, directly or indirectly, implicating other cells such as SchCs.
It has been demonstrated that foetal OECs have the ability to myelinate DRG neurites in vitro, with these cells having different growth requirements to SchCs with regards the assembly of a basal lamina (Devon & Doucette, 1992; Devon & Doucette, 1995) . From those initial studies, it was then demonstrated that OECs can directly myelinate axons after SCI (Akiyama, Lankford, Radtke, Greer, & Kocsis, 2004; Imaizumi et al., 2000a; Imaizumi et al., 2000b; Lankford et al., 2008; Lankford et al., 2014; Sasaki, Lankford, Zemedkun, & Kocsis, 2004; Sasaki, Li, Lankford, Radtke, & Kocsis, 2007) . This was shown with engineered green fluorescent protein (GFP), alkaline phosphataseexpressing OECs, transgenic pig OECs expressing the human complement inhibitory protein CD59, or with OECs preloaded with 5-(and 6)-carboxyfluorescein diacetate succinimidyl ester. When transplanted, these OECs were able to myelinate the majority of axons in a peripheral-like manner, about half of which were associated with compacted myelin (Sasaki et al., 2004) . Further evidence came from using transgenic mice expressing GFP under the control of CNPase promoter. This fluorescent protein was expressed in the OB in vivo and in culture, co-localizing with the OEC marker, p75NTR. When transplanted after sciatic nerve transection, these GFP-expressing OECs were associated to and myelinated the regenerating peripheral nerve (Radtke, Sasaki, Lankford, Gallo, & Kocsis, 2011) . Furthermore, OEC transplantation has been shown to promote remyelination in models of SC demyelination, both in rodents and primates Barnett et al., 2000; Franklin, Gilson, Franceschini, & Barnett, 1996; Imaizumi et al., 1998; Lankford et al., 2008; Radtke et al., 2004; .
However, other conflicting findings have also been presented, for example when invasive SchCs appeared to be responsible for remyelination as opposed to engineered Lac-Z expressing OECs (Boyd, Lee, Skihar, Doucette, & Kawaja, 2004) . These OECs might have attracted these exogenous SchCs to the SC and indeed, OEC conditioned medium may be a chemoattractant for SchCs in vitro, with NGF representing an important driver of this effect . Moreover, oligodendrocyte precursor proliferation has been proposed to influence remyelination after SCI (Czepiel, Boddeke, & Copray, 2015; Jiang et al., 2008) , such that the activation of this glial lineage after OEC transplantation may be in part involved in remyelination, together with SchCs (Masgutova, Savchenko, Viktorov, Masgutov, & Chelyshev, 2010) .
| Combining OECs with other treatments
As indicated above, OECs can induce axonal repair and/or functional improvement in SCI, alone or when combined with SchC grafts, SchCs and chondroitinase, or with SchCs combined with elevated cAMP (Bunge, 2008; Fouad et al., 2005; Fouad, Pearse, Tetzlaff, & Vavrek, 2009; Ramon-Cueto et al., 1998; Takami et al., 2002; Vavrek, Pearse, & Fouad, 2007) . However, in some SCI models, SchC grafts and OECs have a similar capacity to promote functional/electrophysiological recovery and/or regeneration of certain axonal tracts Imaizumi et al., 2000a; Imaizumi et al., 2000b) , improving the efficacy of SchCs on occasion (Takami et al., 2002) .
OECs have also been used in conjunction with several kinds of stem cells and in a model of incomplete SCI, better BBB functional recovery was achieved by transplanting foetal neural stem cells along with adult OECs (Wang et al., 2010) . In addition, co-transplantation of foetal (Deng et al., 2008) or adult OECs (Wu et al., 2015) with adult human (Deng et al., 2008) or rat (Wu et al., 2015) BM-MSCs had a beneficial effect in a contusion SCI model, as judged by histopathological and functional evaluation (BBB and transcranial magnetic motorevoked potentials). Hind limb recovery may have been related to a significant anti-apoptotic effect (Wu et al., 2015) , although significant effects on tissue sparing have been seen and functional tests (BBB)
improved following transplantation of juvenile LP-OECs or BM-MSCs to treat compressive SCI (Amemori, Jendelova, Ruzickova, Arboleda, & Sykova, 2010) . In this study there were no significant differences between the individual treatments and combining both types of cells (Amemori et al., 2010) .
In a study combining glial scar ablation, LP grafts and transplantation of cultured LP-OECs from adult rats prevented scar reformation, along with an increase in the repaired tissue (transplanted tissue/cells integration), a marked reduction or even the disappearance of the lesion cavity, and a significant increase in the P0 positive myelination.
Surprisingly, there was no significant functional restoration according to the BBB (Zhang, Huang, Gates, & Holmberg, 2011) . Several possibilities for these effects were discussed but the correct interpretation should probably take into account that the impairment in the BBB after the contusion lesion was not very large in this study when compared with similar SCI studies (Deng et al., 2008; Wu et al., 2015) . Moreover, values pre-surgery were not reported nor was a sham operated control group used. Carlos Lima's therapeutic approach for SCI involved OM transplantation (see Section 6), based on the idea of that this tissue is composed of multiple cell types, including OECs and stem cells. As such, the use of the OM avoids the need to expose cells to an artificial tissue culture environment (Lima et al., 2006) . In recent years, a stem cell-like population has been identified in the OE and another one in the LP (Tome et al., 2009) . OM-MSCs have been isolated from the LP and characterized in different laboratories (Delorme et al., 2010; Feron et al., 2013; Girard et al., 2011; Lindsay et al., 2010; Lindsay et al., 2013; . Transplanted olfactory MSCs differentiated into neurons and stimulated neuroplasticity after lesions in the hippocampus, promoting neurogenesis . These cells could produce dopaminergic neurons in a rat model of Parkinson disease (Murrell et al., 2008) and recently, it was demonstrated that OM-MSCs from the LP promote remyelination and the earlier recovery of gait coordination in a model of incomplete SCI al., 2016) . OM-MSC conditioned medium promoted myelination in vitro (Lindsay et al., 2013) . OEC conditioned medium can induce neural stem cells, umbilical cord blood MSCs and OM-MSCs to differentiate into neurons (Duan et al., 2011; Ge, Liu, Liu, & Lu, 2016; Zeng et al., 2013) . Indeed, the combined use of OM-OECs with OM-MSCs was proposed as a novel strategy for SCI via autologous transplantation of both cell types (Ge et al., 2016) . OECs could attenuate the astrocytic reaction and retraction of the rubrospinal axons, producing a tendency towards a smaller lesion, neither OECs alone nor the combined treatment could promote regrowth of the axotomized axons through the lesion site (Bretzner et al., 2010) .
The therapeutic effect of combining OEC transplantation with acidic fibroblast growth factor (aFGF) has also been evaluated using complete SC transection (Botero, 2015; Gomez, 2009) . Local reparative activation was evident in the injured SC tissue, leading to functional recovery as evaluated using the BBB scale (Botero, 2015; Gomez, 2009 ). This combination functioned in a similar way in chronic and acute SCI (Botero, 2015) when evaluated using a neurological assessment (Gomez et al., 2015) . Transplanted rats showed motor and sensory These results confirm the positive effect of transplanting OECs and aFGF to induce SCI recovery (Botero, 2015) .
| OE CS T O CU R E S CI : C LI N I CA L S T U DI E S
Studies with OECs have not only been performed in experimental animal models but a moderate number of clinical studies have also been carried out on humans in several countries. The human foetal OB is a viable source of OECs for heterologous transplantation, as has been used in China. Although these heterologous transplants have been performed on a large number of SCI patients (Huang et al., 2009) , and in patients with amyotrophic lateral sclerosis or Friedreich's Ataxia, it is difficult to ascertain the contribution of the OEC component in these bulb-derived cell mixtures. This clinical approach has also raised ethical and legal issues in other countries (Watts, 2005) . Several problems have to be considered when evaluating the results of the use of this treatment in China:
The source of the foetal OB-derived cells for the patient treatment must be obtained in accordance with applicable Chinese guidelines, both institutional and governmental.
The transplanted foetal OB-derived cells were not well characterized in most cases (see exception below: Guest, Herrera, & Qian, 2006).
A rigorous clinical study was not performed, incorporating the corresponding controls or with a complete evaluation of the patients before and after transplantation surgery.
This surgery was offered to all patients willing a travel to China and pay for a cure for their condition.
There has been no systematic follow-up by independent clinicians.
Nevertheless, there have been some independent evaluations of this procedure and in one of these, the results from seven patients transplanted in China were disappointing, with no functional improvement and some perioperative morbidity (Dobkin, Curt, & Guest, 2006 were implicated in these early responses, although the need for further independent analysis was recognized . Autologous transplants have been carried out in seven patients using OM grafts in Portugal, all of which showed improvement in their ASIA motor scores. Two ASIA A patients became ASIA C (Lima et al., 2006) , although some adverse effects were reported, such as a sensory decline in one patient and transient pain that responded to medication.
A collaborative Indian pilot study was not able to demonstrate efficacy in five chronic, motor complete SCI patients (Chhabra et al., 2009 ).
Moreover, a later study that enrolled 20 patients that underwent pre- Chinese studies, these results were not independently confirmed and raised some doubts in the field (personnel observations). More evidence will be needed in the future to support this treatment.
Other groups have worked with mucosal-derived cultured OECs and a phase I/IIa clinical trial was completed in Australia at The National Centre for Adult Stem Cell Research, Griffith University (Feron et al., 2005; Mackay-Sim et al., 2008) . The main objective was to test the feasibility and safety of autologous transplantation of OECs to treat SCI in humans (Feron et al., 2005) . The participants were three paraplegic males ranging from 18 to 55 years old, with stable and complete thoracic injuries, and three matched control patients. The patient's
OECs were grown and purified in vitro from nasal biopsies and the cells were characterized for the OEC markers (S100 1 and GFAP 1 >95%
and p75NTR Tabakow et al., 2013) . However, the patient that improved from SCI ASIA A to C with OM transplantation had suffered a knife injury to the SC at T10-T11, a very particular type of lesion with unique features (Guest & Dietrich, 2015) .
In 2014 a clinical case was described in which autologous transplantation of OB OECs/ONFs was performed in a combinatorial treatment that included re-transection of the SC to eliminate scar tissue . The treated 38 year old patient presented a very particular type of penetrating SC lesion inflicted with a knife at the T9 level, similar to that of the patient in a previous study (Tabakow et al., 2013) . This stab lesion left a thin rim of tissue on the right lateral column of the SC that connected both stumps of the cord, which were In addition to re-sectioning the lesion (to remove the inhibitory glial scar), in this case OB glial cells were combined with peripheral nerve bridges (composed of SchCs, ONFs and intercellular matrix) and intensive rehabilitation, introducing new parameters to the therapeutic strategy . The possible spontaneous recovery from this lesion was very low, taking into account that the patient had been under rehabilitation for 21 months prior to the intervention. Although in the first 13 months after lesion the patient was subjected to a number of different rehabilitation programs, these were incomplete and interrupted because of the need to treat different complications (infections, pressure ulcers and inflammation of the deep venous system of the lower limbs). Hence, the patient was subjected to an additional intense neurorehabilitation program for 8 months before receiving the experimental treatment to rule out spontaneous recovery. This program did not produce an improvement in his condition, which only ameliorated impressively after the surgery. Therefore, and taking into account data from different studies on late spontaneous recovery (see discussion in Tabakow et al., 2014) , the probability of spontaneous recovery in this patient was considered to be lower than 1% . However, examining the published data of this study more closely, there appeared to be possible decompression of a cystic structure that extended from the ventral cord to the dorsal arachnoid, maintained within the separated dural layers, which may have contributed to recovery in conjunction with the detethering of dural adhesions (Guest & Dietrich, 2015) . With respect to the mechanisms underlying the functional changes, the possibility of unprecedented extent of axonal regeneration (10 cm) was considered, yet some concerns were raised about this matter. For example, the preserved tissue in the lateral column of the right SC might contain corticospinal axons that sent out collaterals, which could explain motor function recovery in the left leg (the latency of motor evoked potentials returning to the normal range).
There are several issues that must be defined more accurately in relation to the clinical use of OECs. While the method of culture is fundamental, it may not be possible to standardize transplants for different subjects, which will make it even more difficult to interpret new studies (Guest & Dietrich, 2015) . The OM seems to be the most accessible tissue to prepare OECs for autologous transplantation. In fact, patients with SC transection who were transplanted with OM- (Tabakow et al., 2013) or OB-OECs had similar outcomes, although peripheral nerve autografts were not used in the former.
Thus, the need to use OB and peripheral grafts is not fully demonstrated in these studies (Guest & Dietrich, 2015) .
Transplantation of OM cells has produced different results to that of OB cells in the same rhizotomy model of lesion. This was attributed to the different composition of the cultures, which we have already addressed above, and to the low percentage of p75NTR positive OECs in the OM preparations (Ibrahim et al., 2014) . However, in this respect it is necessary to consider the two clinical studies carried out in Poland (Tabakow et al., 2013; Tabakow et al., 2014) . In the later study, a combined treatment was given to the patient with the transected SC, transplantation with 5 3 10 5 OB-cells with 16% of p75NTR 1 OECs , whereas p75NTR and S100 expression was used to identify OECs in the OEC/ONF mixture in the earlier study.
The patient denoted as T1, also with the SC transected by a knife, recovered similarly to the patient in the 2014 study (ASIA A to C).
Thus, both patients presented similar types of lesion (transection) and a similar degree of recovery. Patient T1 recovered the best of the three patients in this study with the OM cells grafted, even though he was transplanted with the smallest number of cells (1.8 3 10
6
) and with the lowest proportion of S100 1 OECs (10%) of the three patients (Tabakow et al., 2013) . The other two patients had a different type of lesion (compression), and they were transplanted with 1.9 3 10 6 and 21.2 3 10 6 OM cells, 25.7% and 12% of which were S100 1 , respectively. The functional recovery of these patients was poorer than both patients with the transected SC, although the total number of OECs they received was much higher. It is possible that surpassing a threshold of "true" OECs in the culture is sufficient to ensure an effect, and that specific factors related to each patient might account for these differences, such as the type of injury (Guest & Dietrich, 2015) or treatment. However, the mixed nature of the OM cultures, containing different cell types in addition to OECs, such as OM-MSC, ONFs and/ or other p75NTR 2 cells would do necessary a more accurate characterization. This can be fundamental to achieve uniform, or at least more predictable, treatments.
In some cases it might not be possible to establish a primary culture from the mucosa for different reasons. For example, in the case of the patient indicated above and they have also to be considered (Czyz, Tabakow, HernandezSanchez, Jarmundowicz, & Raisman, 2015; Guest & Dietrich, 2015) .
The rationale behind our previous approaches (Moreno-Flores et al., 2003b; Moreno-Flores et al., 2003a) aimed to resolve all these problems, including the composition of the cultures and the availability of regenerative OECs. We prepared primary cultures from human OB-OECs cadaver donors and we reversibly immortalized them Lim et al., 2010) . Additionally, we also 
| CON CL U SI ONS A N D FU T U RE P ER SP EC TI V ES
In this review, we have set out the current status of research into
OECs and the possibility of using these cells to treat SCI: morphological aspects, physiological functions, and the factors that they produce and that can be used to restore CNS function. Taking into account all the biological characteristics described in this review, we conclude that these cells possess a notable ability to stimulate axon repair/plasticity and/or to support the sparing of axons in the CNS.
These studies have revealed that OECs can act as therapeutic agents in several different ways. They are able to stimulate angiogenesis, and to modify PNNs and the glial scar (producing different proteinases like MMP2 and PAI-1; Figure 4 ), especially when mixed with reactive astrocytes. In this way they can foster the outgrowth of axons to differing degrees, as well as through the production of trophic factors like NGF, BDNF, and GDNF. Finally, they can also produce new myelination of the injured/repaired axons by direct or indirect mechanisms.
OECs are a unique type of glia found exclusively in the olfactory system and as such, they are relatively accessible in rodents and humans.
Therefore, they can be extracted for autologous grafting, which removes the likelihood of producing an immune rejection response. 
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